Buprenorphine is a controlled substance under international drug control conventions. In many countries, it is classified as a Schedule III drug, reflecting its potential for abuse. Regulations require prescribers to undergo specific training to dispense buprenorphine, aiming to prevent diversion and misuse while ensuring access for those who need it for addiction treatment.
